Roswell Park Comprehensive Cancer Center Chief of Cancer Screening and Survivorship Mary Reid, BSN, MSPH, PhD said, “Governor Kathy Hochul has been an incredible advocate for the health and wellness of all New Yorkers and a champion for early detection of cancer to save the most lives. Lung cancer remains our biggest cancer killer, statewide and worldwide, but thanks to the thoughtful leadership of Governor Hochul and Majority Leader Crystal Peoples-Stokes, we can overcome barriers that have kept vulnerable community members from accessing effective, safe, noninvasive, life-saving lung cancer screening."
Embedded Files
If you would like to join the LCSAT, please contact Whitney Mendel at Whitney.Mendel@RoswellPark.org or call 716.845.1300 ext. 7846
Find lung cancer screening facilities in your area by visiting the new NY Lung Cancer Screening Locator website:
Find lung cancer screening facilities in your area by visiting the new NY Lung Cancer Screening Locator website:
New State of Tobacco Control 2026
New State of Tobacco Control 2026
About Us
About Us
NYS Cancer Consortium’s Lung Cancer Screening Action Team Membership RosterMembership Roster
Membership Roster
LCSAT Project Coordinator
LCSAT Project Coordinator
Our Mission, Vision, Goals, & Objectives
Our Mission, Vision, Goals, & Objectives
Mission
Mission
To combat the devastating effects of lung cancer (LC) on New York State, the NYS Lung Cancer Screening Task Force will take the lead on mobilizing multi-level resources to decrease lung cancer mortality by increasing lung cancer screening using guideline-driven, evidence-based strategies.
Goals & Objectives
Goals & Objectives
Increase in rates of lung cancer screening
Participation by community PCPs in education programs about lung cancer screening guidelines and nodule management
Increase the numbers of radiology practices providing LDCT screening: increase in the number of radiology practices in underserved areas providing LDCT screening
Address barriers to achieving increased LC screening rates including:
improving access to low-dose CT (LDCT);
coordinating education of primary care practitioners (PCP) in approved screening guidelines & management of lung nodules;
engaging radiology practices, particularly in underserved areas to engage in LC screening;
mobilizing experienced experts to facilitate nodule management to PCPs and radiologists;
targeting the most at-risk urban and rural populations to enhance LC screening;
coordinating these efforts with an aggressive comprehensive smoking cessation campaign.
LCS News
LCS News
Micro-Education Series for Primary Care
Micro-Education Series for Primary Care
From CPT Codes to Nodule Management
From CPT Codes to Nodule Management
Brought to you by GO2 for Lung Cancer
Brought to you by GO2 for Lung Cancer
Primary Care Practice Handbook to Increase Lung Cancer Screening
Primary Care Practice Handbook to Increase Lung Cancer Screening
Steps-For-Increasing-Lung-Cancer-Screening-Guide.pdf
NY LCS Related Legislation Awaiting Governor's Signature
NY LCS Related Legislation Awaiting Governor's Signature
Lung Cancer Screening HEDIS Measure - Indefinitely Paused
Lung Cancer Screening HEDIS Measure - Indefinitely Paused
"Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s individual condition. Over the past few months, we have heard countless stories of the difficulties patients face in attempting to access this important testing. It’s time for that to change.
"This legislation will help address a significant barrier and bring the promise of precision medicine to more patients no matter their income, race or where they live. This can provide many benefits to patients including better outcomes, improved quality of life and in some cases reduced costs from bypassing ineffective therapies." - Michael Davoli, Senior Government Relations Director, ACS CAN NY
Senate Bill 1196 aims to enable more New Yorkers to benefit from biomarker testing, a critical step in accessing precision medicine treatments. The bill now heads to the Assembly
Senate Bill 1196 aims to enable more New Yorkers to benefit from biomarker testing, a critical step in accessing precision medicine treatments. The bill now heads to the Assembly
Meet Eddy (Early Detection Driven to You)
Meet Eddy (Early Detection Driven to You)
Helpful Resources
Helpful Resources
Page updated
Google Sites
Report abuse